· Original article
QSR earnings preview: Mizuho sets $85 target ahead of results
QSR earnings are due October 29, 2026. Mizuho has an Outperform rating and $85 target, while analysts expect $1.08 in adjusted EPS.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,074 · Page 295 / 340
· Original article
QSR earnings are due October 29, 2026. Mizuho has an Outperform rating and $85 target, while analysts expect $1.08 in adjusted EPS.
· Original article
The FII conference in Riyadh has moved from October 2026 to 2027. New dates are pending, while existing registrations and partnerships remain valid.
· Original article
Halliburton earnings show higher adjusted profit on flat quarterly revenue, while management’s early 2027 outlook targets operating margins near 15%.
· Original article
AWS TorchNeuron enters public beta, letting developers run PyTorch on Trainium chips with a small code change and support for familiar tools.
· Original article
3M earnings increased in the third quarter of 2026 as margins widened, and the company raised full-year adjusted EPS guidance to $9.10–$9.15.
· Original article
Royal Caribbean earnings could top third-quarter guidance, William Blair said on October 20, despite fuel costs and ship-scheduling pressures.
· Original article
ExxonMobil shares fell on October 20 as the put/call ratio rose above its typical level. Third-quarter results are scheduled for October 30, 2026.
· Original article
TJX executive transition keeps Kenneth Canestrari employed through April 2027, with an earlier end to officer duties and limits on future incentive awards.
· Original article
Arcus Biosciences reported 35-month median survival in late-line kidney cancer patients, with another Phase 3 casdatifan trial planned by year-end.
· Original article
Silvercorp shares fell 3.3% after preliminary Q2 fiscal 2027 revenue declined 13%, as lower mine output outweighed higher silver and gold prices.
· Original article
GEnx deliveries topped 50 in Q3 2026 as Boeing planned higher 787 production. GE Aerospace also raised its outlook after stronger orders and earnings.
· Original article
Nike basketball plans a Cade Cunningham signature shoe for the second half of the 2026–27 NBA season, alongside the updated Giannis Freak 8.
Charts and market data by TradingView. Availability and delays vary by exchange.